The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply
But for people who currently use medications like Wegovy and Ozempic for weight loss, you may face one of the following issues that have become common across the U.S
The Founders' Welcome Kit gives eligible monthly subscription customers non-consumable references for product-document requests, handling reminders, and support
If you want to know how to get approved for glp-1, approach it like a healthcare navigator would
Many employers that offer health plans that cover GLP-1 drugs impose conditions that plan participants must meet to qualify for such coverage
Mar 10, 2026 Tired of conflicting information about why your GLP-1 medication stopped working